Abstract
Non-nucleoside reverse transcriptase inhibitors (NNRTI) has a definitive role and most commonly used in treatment of HIV infection. NNRTI act by binding to specific binding site (non-nucleoside binding pocket-NNBP) in reverse transcriptase (RT) enzyme. With the objective of developing efficient NNRTI, we have designed various Isatin analogs for effective treatment of AIDS and were subjected to molecular docking studies on five different crystal structures of RT complexed with five different ligands Nevirapine, Delaviridine, Efavirenz, Etravirine, and Rilpivirine. Combined dock-score of compound N21, N11, N23 was found to be comparable with standards indicated that Isatin analogs have good binding affinity for NNBP. Docking results suggested that these types of compounds could be binding in the NNRTI binding site in a similar mode to a known non-nucleoside inhibitors. ADME properties of Isatin analogs were also analyzed using Qikprop 2.5 tool of Schrodinger software.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balzarini J (2004) Current status of nonnucleoside reverse transcriptase inhibitors of human immuno deficiency virus type 1. Curr Top Med Chem 4:921–944
Barre Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamart S (1983) Isolation of T-lymphotropic rétrovirus from a patient at risk for acquired immuno deficiency syndrome (AIDS). Science 220:868–871
Bhattacharya SK, Chakraborti A (1998) Indian J Exp Biol 36:118–121
Carlson HA, Masukawa KM, McCammon JA (1999) Method for including the dynamic fluctuations of a protein in computer-aided drug design. J Phys Chem 103:10213–10219
Carlson HA, Masukawa KM, Rubins K, Bushman FD, Jorgensen WL, Lins RD, Briggs JM, McCammon JA (2000) Developing a dynamic pharmacophore model for HIV-1 integrase. J Med Chem 43:2100–2114
Daisley RW, Shah VK (1984) Synthesis and antibacterial activity of some 5-nitro-2(3H)-one and their N-Mannich bases. J Pharm Sci 73:407–409
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH (2004) Glide: a new approach for rapid, accurate docking and scoring: 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177
Gottlieb MS, Schro R, Schankar HM, Weisman JD, Fan PT, Wolf RA, Saxon A (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosextual men: evidence of new acquired cellular immunodeficiency. N Engl J Med 305:1425
Hayes MJ, Stein M, Weiser J (2004) Accurate calculations of ligand binding free energies. J Phys Chem 108:3572–3580
Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics of organic liquids. J Am Chem Soc 118:11225–11236
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26
Pandeya SN, Sriram D, Nath G, DeClercq E (1999) Synthesis and anti-HIV activity of 4-[(1, 2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4, 6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives. Eur J Pharm Sci 9:25–31
Pandeya SN, Sriram D, Nath G, Clercq D, Arzneim Forsch (2000) Synthesis, antibacterial, antifungal and anti-HIV activities of Norfloxacin Mannich bases. Eur J Med Chem 50:55–60
Piscapo B, Dium MV, Godliardi R, Cucciniello M, Veneruso G (1987) Studies on heterocyclic compounds indole-2,3-dione derivatives variously substituted hydrazones with antimicrobial activity. Bol Soc Ital Biol Sper 63:827–830
Ragno R, Frasca S, Manetti F, Brizzi A, Massa S (2005) HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. J Med Chem 48:200–212
Schiifer W, Friebe W, Leinert H, Mertens A, Poll T, Saal W, Zilch H, Nuber B, Zieglertsf ML (1993) Non-nucleoside inhibitors of HIV-f reverse transcriptase: molecular modeling and X-ray structure investigations. J Med Chem 36:726–732
Sriram D, Bal TR, Yogeeswari P (2005) Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS. design, synthesis and biological evaluation. Farmaco 60:377–384
Varma RS, Nobles WL (1967) Synthesis and antiviral and antibacterial activity of certain N-dialkylaminomethyl isatin β thiosemicarbazone. J Med Chem 10:972–974
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pawar, V.S., Lokwani, D.K., Bhandari, S.V. et al. Design, docking study and ADME prediction of Isatin derivatives as anti-HIV agents. Med Chem Res 20, 370–380 (2011). https://doi.org/10.1007/s00044-010-9329-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-010-9329-y